Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of IVT MHU650 in macular edema patients. The trial also encompassed diabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Macular Edema
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• IVT MHU650 (MHU650)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Macular Edema, Diabetic Macular Edema | Phase 1 | Status: COMPLETED